Open AccessContinuous glucose monitoring‐enabled insulin‐pump therapy in diabetic pregnancy
Author(s) -
Secher Anna L.,
Schmidt Signe,
Nørgaard Kirsten,
Mathiesen Elisabeth R.
Publication year - 2010
Publication title -
acta obstetricia et gynecologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.401
H-Index - 102
eISSN - 1600-0412
pISSN - 0001-6349
DOI - 10.3109/00016349.2010.498499
Subject(s) - medicine , pregnancy , insulin pump , hypoglycemia , insulin , neonatal hypoglycemia , diabetes mellitus , type 1 diabetes , obstetrics , gestation , pediatrics , endocrinology , gestational diabetes , genetics , biology
We describe the feasibility of continuous glucose monitoring (CGM)‐enabled insulin‐pump therapy during pregnancy in a woman with type 1 diabetes, who was treated with CGM‐enabled insulin‐pump therapy in her third pregnancy. During her first pregnancy, the woman was treated with multiple daily injections and baseline HbA1c was 8.9%. Due to pre‐eclampsia, the child was born preterm, and had neonatal hypoglycemia. In the planning of the second pregnancy, insulin‐pump therapy was initiated, resulting in an HbA1c of 6.8% in early pregnancy. Due to pre‐eclampsia, the second child was born preterm, but without neonatal morbidity. Before her third pregnancy, CGM‐enabled insulin‐pump therapy was introduced, and HbA1c was 6.4% in early pregnancy. The patient was satisfied with this therapy, pre‐eclampsia did not occur, and the child was born at term without neonatal morbidity. CGM‐enabled insulin‐pump therapy appears feasible in diabetic pregnancies.